Bio-Gene Technology Limited (ASX:BGT) Directors Insider Transactions
The Directors and Chief Executives of Bio-Gene Technology Limited (ASX:BGT) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the Bio-Gene Technology Limited's shares in the stock market. Below table shows the list of insider transactions as reported by Bio-Gene Technology Limited to the ASX stock exchange.
An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.
Bio-Gene Technology Limited Directors/Insider Transactions Activity
List of Insider trades activity from Bio-Gene Technology Limited (BGT).
| Date | Director | Director's Title | Shares | Value | Note |
|---|---|---|---|---|---|
| 21 Jul 2025 | Ding (Huong Soo Alex) | Non Executive Chairman | 21,739,130 | 326,086 | Other at price 0.02 per share. |
| 21 Jul 2025 | Grogan (Tim) | Chief Executive Officer | 217,392 | 3,260 | Other at price 0.02 per share. |
| 21 Jul 2025 | Guthrie (Andrew Wallace) | Director (Non-Executive) | 217,392 | 3,260 | Other at price 0.02 per share. |
| 21 Jul 2025 | May (Peter Donald) | Director (Executive) | 217,392 | 3,260 | Other at price 0.02 per share. |